PubMed:32610873 / 2863-3050 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T21","span":{"begin":0,"end":187},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"134","span":{"begin":10,"end":17},"obj":"Species"},{"id":"135","span":{"begin":148,"end":156},"obj":"Species"}],"attributes":[{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:9606"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%)."}

{"project":"Covid19_manual_annotation_v2","denotations":[{"id":"134","span":{"begin":10,"end":17},"obj":"Species"},{"id":"T108","span":{"begin":165,"end":177},"obj":"Disease"},{"id":"T109","span":{"begin":179,"end":184},"obj":"Number"},{"id":"T126","span":{"begin":148,"end":156},"obj":"Species"},{"id":"T127","span":{"begin":162,"end":164},"obj":"Without"},{"id":"T128","span":{"begin":45,"end":54},"obj":"Disease"},{"id":"T129","span":{"begin":93,"end":107},"obj":"Status_of_Care"},{"id":"T130","span":{"begin":108,"end":115},"obj":"Type"},{"id":"T131","span":{"begin":71,"end":75},"obj":"PositiveRegulation"},{"id":"T241","span":{"begin":5,"end":6},"obj":"Unit"},{"id":"T242","span":{"begin":184,"end":185},"obj":"Unit"},{"id":"T52","span":{"begin":0,"end":5},"obj":"Number"}],"relations":[{"id":"R137","pred":"has_a","subj":"T128","obj":"134"},{"id":"R138","pred":"is_a","subj":"134","obj":"T131"},{"id":"R139","pred":"is_a","subj":"T131","obj":"T129"},{"id":"R142","pred":"of_a","subj":"T127","obj":"T108"},{"id":"R143","pred":"has_a","subj":"T108","obj":"T126"},{"id":"R144","pred":"against","subj":"T126","obj":"T131"},{"id":"R218","pred":"of_a","subj":"T130","obj":"T129"},{"id":"R273","pred":"associate_with","subj":"T52","obj":"T241"},{"id":"R274","pred":"associate_with","subj":"T52","obj":"134"},{"id":"R275","pred":"associate_with","subj":"T109","obj":"T242"},{"id":"R276","pred":"associate_with","subj":"T109","obj":"T126"}],"attributes":[{"id":"A262","pred":"tao:has_database_id","subj":"T126","obj":"Tax:9606"},{"id":"A266","pred":"tao:has_database_id","subj":"T128","obj":"MESH:D015897"},{"id":"A267","pred":"ForCovid19","subj":"T128","obj":"comorbidity"},{"id":"A264","pred":"tao:has_database_id","subj":"T108","obj":"MESH:D015897"},{"id":"A265","pred":"ForCovid19","subj":"T108","obj":"comorbidity"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"BioProject","uri":"https://www.ncbi.nlm.nih.gov/bioproject/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"},{"prefix":"HP","uri":"https://hpo.jax.org/app/browse/term/HP:"},{"prefix":"BioSample","uri":"https://www.ncbi.nlm.nih.gov/biosample/"}],"text":"60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%)."}

{"project":"Zoonoses","denotations":[{"id":"134","span":{"begin":10,"end":17},"obj":"Species"},{"id":"T108","span":{"begin":165,"end":177},"obj":"Disease"},{"id":"T109","span":{"begin":179,"end":184},"obj":"Number"},{"id":"T126","span":{"begin":148,"end":156},"obj":"Species"},{"id":"T127","span":{"begin":162,"end":164},"obj":"Without"},{"id":"T128","span":{"begin":45,"end":54},"obj":"Disease"},{"id":"T129","span":{"begin":93,"end":107},"obj":"Status_of_Care"},{"id":"T130","span":{"begin":108,"end":115},"obj":"Type"},{"id":"T131","span":{"begin":71,"end":75},"obj":"PositiveRegulation"},{"id":"T241","span":{"begin":5,"end":6},"obj":"Unit"},{"id":"T242","span":{"begin":184,"end":185},"obj":"Unit"},{"id":"T52","span":{"begin":0,"end":5},"obj":"Number"}],"relations":[{"id":"R139","pred":"is_a","subj":"T131","obj":"T129"},{"id":"R142","pred":"of_a","subj":"T127","obj":"T108"},{"id":"R218","pred":"of_a","subj":"T130","obj":"T129"},{"id":"R273","pred":"associate_with","subj":"T52","obj":"T241"},{"id":"R274","pred":"associate_with","subj":"T52","obj":"134"},{"id":"R275","pred":"associate_with","subj":"T109","obj":"T242"},{"id":"R276","pred":"associate_with","subj":"T109","obj":"T126"},{"id":"R88570","pred":"has_a","subj":"134","obj":"T128"},{"id":"R88571","pred":"has_status","subj":"134","obj":"T129"},{"id":"R88572","pred":"against","subj":"T131","obj":"T126"},{"id":"R88573","pred":"cause_of","subj":"T128","obj":"T131"},{"id":"R88574","pred":"has_a","subj":"T126","obj":"T108"}],"attributes":[{"id":"A266","pred":"tao:has_database_id","subj":"T128","obj":"MESH:D015897"},{"id":"A267","pred":"ForCovid19","subj":"T128","obj":"comorbidity"},{"id":"A264","pred":"tao:has_database_id","subj":"T108","obj":"MESH:D015897"},{"id":"A265","pred":"ForCovid19","subj":"T108","obj":"comorbidity"},{"id":"A262","pred":"tao:has_database_id","subj":"T126","obj":"Tax:9606"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:9606"}],"text":"60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%)."}

{"project":"Covid19_manual_annotation","denotations":[{"id":"134","span":{"begin":10,"end":17},"obj":"Species"},{"id":"T68","span":{"begin":55,"end":65},"obj":"Condition"},{"id":"T108","span":{"begin":165,"end":177},"obj":"Disease"},{"id":"T109","span":{"begin":179,"end":185},"obj":"Percent"},{"id":"T52","span":{"begin":0,"end":6},"obj":"Percent"},{"id":"T126","span":{"begin":148,"end":156},"obj":"Species"},{"id":"T127","span":{"begin":162,"end":164},"obj":"Negative"},{"id":"T128","span":{"begin":45,"end":54},"obj":"Disease"},{"id":"T129","span":{"begin":93,"end":107},"obj":"Condition"},{"id":"T130","span":{"begin":108,"end":115},"obj":"Condition"},{"id":"T131","span":{"begin":71,"end":75},"obj":"PositiveRegulation"}],"relations":[{"id":"R144","pred":"of_a","subj":"T126","obj":"T109"},{"id":"R145","pred":"of_a","subj":"134","obj":"T52"},{"id":"R146","pred":"is_a","subj":"T127","obj":"T108"},{"id":"R147","pred":"has_a","subj":"T108","obj":"T126"},{"id":"R148","pred":"has_status","subj":"134","obj":"T68"},{"id":"R149","pred":"of_a","subj":"T128","obj":"T68"},{"id":"R150","pred":"of_a","subj":"T130","obj":"T129"},{"id":"R151","pred":"is_a","subj":"T131","obj":"T130"},{"id":"R152","pred":"has_status","subj":"T68","obj":"T129"},{"id":"R153","pred":"against","subj":"T126","obj":"T131"}],"attributes":[{"id":"A266","pred":"tao:has_database_id","subj":"T128","obj":"MESH:D015897"},{"id":"A267","pred":"ForCovid19","subj":"T128","obj":"comorbidity"},{"id":"A262","pred":"tao:has_database_id","subj":"T126","obj":"Tax:9606"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:9606"},{"id":"A219","pred":"ForCovid19","subj":"T68","obj":"comorbidity"},{"id":"A264","pred":"tao:has_database_id","subj":"T108","obj":"MESH:D015897"},{"id":"A265","pred":"ForCovid19","subj":"T108","obj":"comorbidity"}],"text":"60.27% of patient population with underlying co morbid conditions were more prone to develop symptomatology complex as compared to that observed in patients with no co morbidity (18.42%)."}